Synergistic Fungicidal Active Substance Combinations

ABSTRACT

The novel active compound combinations of a carboxamide of the general formula (I) (group 1) 
     
       
         
         
             
             
         
       
     
     in which R, G, R 1  and A have the meanings given in the description
 
and the active compound groups (2) to (23) listed in the description have very good fungicidal properties.

The present invention relates to novel active compound combinationscomprising, firstly, known carboxamides and, secondly, further knownfungicidally active compounds, which combinations are highly suitablefor controlling unwanted phytopathogenic fungi.

It is already known that certain carboxamides have fungicidalproperties: for exampleN-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamidefrom EP-A 0 737 682. The activity of these compounds is good; however,at low application rates it is sometimes unsatisfactory. Furthermore, itis already known that numerous triazole derivatives, anilinederivatives, dicarboximides and other heterocycles can be used forcontrolling fungi (cf. EP-A 0 040 345, DE-A 22 01 063, DE-A 23 24 010,Pesticide Manual, 9th Edition (1991), pages 249 and 827, EP-A 0 382 375and EP-A 0 515 901). However, the activity of these compounds, too, isnot always sufficient at low application rates. Furthermore, it isalready known that1-(3,5-dimethylisoxazole-4-sulfonyl)-2-chloro-6,6-difluoro-[1,3]-dioxolo[4,5-f]-benzimidazolehas fungicidal properties (cf. WO 97/06171). Finally, it is also knownthat substituted halopyrimidines have fungicidal properties (cfDE-A1-196 46 407, EP-B-712 396).

Also known are various mixtures of alkylthienylcarboxamides. Theactivity of these mixtures, too, is sometimes unsatisfactory (cf. JP-A11-292715, JP-A 11-302107, JP-A 11-302108, JP-A 11-302109, JP-A11-302110, JP-A 11-302111, JP-A 2001-72511, JP-A 2001-72512, JP-A2001-72513, JP-A 11-322513, JP-A 11-322514, JP-A 2000-53506 and JP-A2000-53507).

This invention now provides novel active compound combinations whichhave very good fungicidal properties and comprise a carboxamide of thegeneral formula (I) (group 1)

in which

-   R represents hydrogen or methyl,-   G represents hydrogen, fluorine or methyl,-   R¹ represents hydrogen, halogen, C₁-C₃-alkyl or C₁-C₃-haloalkyl    having 1 to 7 fluorine, chlorine and/or bromine atoms,-   A represents one of the radicals A1 or A2 below:

-   X represents CH or N,-   R² represents methyl, difluoromethyl or trifluoromethyl,-   R³ represents hydrogen or fluorine,-   R⁴ represents difluoromethyl or trifluoromethyl,    and at least one active compound selected from groups (2) to (23)    below:

Group (2) Strobilurins (2-1) fluoxastrobin (known from DE-A 196 02 095)of the formula

(2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide(known from DE-A 196 46 407, EP-B 0 712 396) of the formula

(2-3) Trifloxystrobin (Known from EP-A 0 460 575) of the Formula

(2-4)(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}-amino)oxy]methyl}phenyl)ethanamide(known from EP-A 0 569 384) of the formula

(2-5)(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)-methyl]phenyl}ethanamide(known from EP-A 0 596 254) of the formula

(2-6) Orysastrobin (Known from DE-A 195 39 324) of the Formula

(2-7)5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]-methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one(known from WO 98/23155) of the formula

(2-8) Dimoxystrobin (Known from EP-A 0 398 692) of the Formula

(2-9) Picoxystrobin (Known from EP-A 0 278 595) of the Formula

(2-10) Pyraclostrobin (Known from DE-A 44 23 612) of the Formula

Group (3) Triazoles (3-1) Azaconazole (Known from DE-A 25 51 560) of theFormula

(3-2) Etaconazole (Known from DE-A 25 51 560) of the Formula

(3-3) Propiconazole (Known from DE-A 25 51 560) of the Formula

(3-4) Difenoconazole (Known from EP-A 0 112 284) of the Formula

(3-5) Bromuconazole (Known from EP-A 0 258 161) of the Formula

(3-6) Cyproconazole (Known from DE-A 34 06 993) of the Formula

(3-7) Hexaconazole (Known from DE-A 30 42 303) of the Formula

(3-8) Penconazole (Known from DE-A 27 35 872) of the Formula

(3-9) Myclobutanil (Known from EP-A 0 145 294) of the Formula

(3-10) Tetraconazole (Known from EP-A 0 234 242) of the Formula

(3-11) Flutriafol (Known from EP-A 0 015 756) of the Formula

(3-12) Epoxiconazole (Known from EP-A 0 196 038) of the Formula

(3-13) Flusilazole (Known from EP-A 0 068 813) of the Formula

(3-14) Simeconazole (Known from EP-A 0 537 957) of the Formula

(3-15) Prothioconazole (Known from WO 96/16048) of the Formula

(3-16) Fenbuconazole (Known from DE-A 37 21 786) of the Formula

(3-17) Tebuconazole (Known from EP-A 0 040 345) of the Formula

(3-18) Ipconazole (Known from EP-A 0 329 397) of the Formula

(3-19) Metconazole (Known from EP-A 0 329 397) of the Formula

(3-20) Triticonazole (Known from EP-A 0 378 953) of the Formula

(3-21) Bitertanol (Known from DE-A 23 24 010) of the Formula

(3-22) Triadimenol (Known from DE-A 23 24 010) of the Formula

(3-23) Triadimefon (Known from DE-A 22 01 063) of the Formula

(3-24) Fluquinconazole (Known from EP-A 0 183 458) of the Formula

(3-25) Quinconazole (Known from EP-A 0 183 458) of the Formula

Group (4) Sulfenamides (4-1) Dichlofluanid (Known from DE-A 11 93 498)of the Formula

(4-2) Tolylfluanid (Known from DE-A 11 93 498) of the Formula

Group (5) Valinamides (5-1) Iprovalicarb (Known from DE-A 40 26 966) ofthe Formula

(5-2) Benthiavalicarb (Known from WO 96/04252) of the Formula

Group (6) Carboxamides (6-1)2-chloro-N-(1,1,3-trimethylindan-4-yl)nicotinamide (known from EP-A 0256 503) of the formula

(6-2) Boscalid (Known from DE-A 195 31 813) of the Formula

(6-3) Furametpyr (Known from EP-A 0 315 502) of the Formula

(6-4) Ethaboxam (Known from EP-A 0 639 574) of the Formula

(6-5) Fenhexamid (Known from EP-A 0 339 418) of the Formula

(6-6) Carpropamid (Known from EP-A 0 341 475) of the Formula

(6-7) 2-chloro-4-(2-fluoro-2-methylpropionylamino)-N,N-dimethylbenzamide(known from EP-A 0 600 629) of the formula

(6-8) Picobenzamid (Known from WO 99/42447) of the Formula

(6-9) Zoxamide (Known from EP-A 0 604 019) of the Formula

(6-10) 3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide (knownfrom WO 99/24413) of the formula

(6-11) Carboxin (Known from U.S. Pat. No. 3,249,499) of the Formula

(6-12) Tiadinil (Known from U.S. Pat. No. 6,616,054) of the Formula

(6-13) Silthiofam (Known from WO 96/18631) of the Formula

Group (7) Dithiocarbamates (7-1) Mancozeb (Known from DE-A 12 34 704)Having the IUPAC Name Manganese ethylenebis(dithiocarbamate) (polymeric)complex with zinc salt (7-2) Maneb (Known from U.S. Pat. No. 2,504,404)of the Formula

(7-3) Metiram (Known from DE-A 10 76 434) Having the IUPAC Name Zincammoniate ethylenebis(dithiocarbamate)-poly(ethylenethiuram disulfide)(7-4) Propineb (Known from GB 935 981) of the Formula

(7-5) Thiram (Known from U.S. Pat. No. 1,972,961) of the Formula

(7-6) Zineb (Known from DE-A 10 81 446) of the Formula

(7-7) Ziram (Known from U.S. Pat. No. 2,588,428) of the Formula

Group (8) Acylalanines (8-1) Benalaxyl (Known from DE-A 29 03 612) ofthe Formula

(8-2) Furalaxyl (Known from DE-A 25 13 732) of the Formula

(8-3) Benalaxyl-M of the Formula

Group (9) Anilinopyrimidines (9-1) Cyprodinil (Known from EP-A 0 310550) of the Formula

(9-2) Pyrimethanil (Known from DD 151 404) of the Formula

Group (10) Benzimidazoles (10-1)6-chloro-5-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-2,2-difluoro-5H-[1,3]dioxolo[4,5-f]-benzimidazole(known from WO 97/06171) of the formula

(10-2) Benomyl (Known from U.S. Pat. No. 3,631,176) of the Formula

(10-3) Carbendazim (Known from U.S. Pat. No. 3,010,968) of the Formula

(10-4) Chlorfenazole of the Formula

(10-5) Fuberidazole (Known from DE-A 12 09 799) of the Formula

(10-6) Thiabendazole (Known from U.S. Pat. No. 3,206,468) of the Formula

Group (11): Carbamates (11-1) Propamocarb (Known from U.S. Pat. No.3,513,241) of the Formula

(11-2) Propamocarb Hydrochloride (Known from U.S. Pat. No. 3,513,241) ofthe Formula

(11-3) Propamocarb-Fosetyl of the Formula

Group (12): Dicarboximides (12-1) Captafol (Known from U.S. Pat. No.3,178,447) of the Formula

(12-2) Folpet (Known from U.S. Pat. No. 2,553,770) of the Formula

(12-3) Iprodione (Known from DE-A 21 49 923) of the Formula

(12-4) Procymidone (Known from DE-A 20 12 656) of the Formula

(12-5) Vinclozolin (Known from DE-A 22 07 576) of the Formula

Group (13): Guanidines (13-1) Dodine (Known from GB 11 03 989) of theFormula

(13-2) Guazatine (Known from GB 11 14 155) (13-3) IminoctadineTriacetate (Known from EP-A 0 155 509) of the Formula

Group (14): Imidazoles (14-1) Cyazofamid (Known from EP-A 0 298 196) ofthe Formula

(14-2) Prochloraz (Known from DE-A 24 29 523) of the Formula

(14-3) Triazoxide (Known from DE-A 28 02 488) of the Formula

(14-4) Pefurazoate (Known from EP-A 0 248 086) of the Formula

Group (15): Morpholines (15-1) Aldimorph (Known from DD 140 041) of theFormula

(15-2) Tridemorph (Known from GB 988 630) of the Formula

(15-3) Dodemorph (Known from DE-A 25 432 79) of the Formula

(15-4) Fenpropimorph (Known from DE-A 26 56 747) of the Formula

Group (16): Pyrroles (16-1) Fenpiclonil (Known from EP-A 0 236 272) ofthe Formula

(16-2) Pyrrolnitrine (Known from JP 65-25876) of the Formula

Group (17): Phosphonates (17-1) Phosphonic Acid (Known as Chemikalie) ofthe Formula

Group (18): Phenylethanamide (Known from WO 96/23793, in Each Case as Eor Z Isomer, Preferably as E Isomer)

(18-1) the compound2-(2,3-dihydro-1H-inden-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)acetamideof the formula

(18-2) the compoundN-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-2-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamideof the formula

(18-3) the compound2-(1-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)acetamideof the formula

(18-4) the compound2-(4-bromophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)acetamideof the formula

(18-5) the compound2-(4-methylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)acetamideof the formula

(18-6) the compound2-(4-ethylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)acetamideof the formula

Group (19): Fungicides (19-1) Acibenzolar-S-Methyl (Known from EP-A 0313 512) of the Formula

(19-2) Edifenphos (Known from DE-A 14 93 736) of the Formula

(19-3) Famoxadone (Known from EP-A 0 393 911) of the Formula

(19-4) Oxadixyl (Known from DEA 30 30 026) of the Formula

(19-5) Spiroxamine (Known from DE-A 37 35 555) of the Formula

(19-6) Dithianon (Known from JP-A 44-29464) of the Formula

(19-7) Metrafenone (Known from EP-A 0 897 904) of the Formula

(19-8) Fenamidone (Known from EP-A 0 629 616) of the Formula

(19-9) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)one (known fromWO 99/14202) of the formula

(19-10) Probenazole (Known from U.S. Pat. No. 3,629,428) of the formula

(19-11) Isoprothiolane (Known from U.S. Pat. No. 3,856,814) of theFormula

(19-12) Kasugamycin (Known from GB 1 094 567) of the Formula

(19-13) Phthalide (Known from JP-A 57-55844) of the Formula

(19-14)N-({4-[(cyclopropylamino)carbonyl]phenyl}sulfonyl)-2-methoxybenzamide ofthe formula

(19-15)2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide(known from WO 01/87822) of the formula

(19-16) Quinoxyfen (Known from EP-A 0 326 330) of the Formula

(19-17) Proquinazid (Known from WO 94/26722) of the Formula

Group (20): (Thio)Urea Derivatives (20-1) Pencycuron (Known from DE-A 2732 257) of the Formula

(20-2) Thiophanate-Ethyl (Known from DE-A 18 06 123) of the Formula

Group (21): Amides (21-1) Fenoxanil (Known from EP-A 0 262 393) of theFormula

(21-2) Diclocymet (Known from JP-A 7-206608) of the Formula

Group (22): Triazolopyrimidines (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine(known from U.S. Pat. No. 5,986,135) of the formula

(22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine(known from WO 02/38565) of the formula

(22-3)5-chloro-6-(2-chloro-6-fluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine(known from U.S. Pat. No. 5,593,996) of the formula

(22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine(known from DE-A 101 24 208) of the formula

(22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo[1,5-a]pyrimidine-7-amine(known from U.S. Pat. No. 5,593,996) of the formula

Group (23): Iodochromones (23-1)2-butoxy-6-iodo-3-propylbenzopyran-4-one (known from WO 03/014103) ofthe formula

(23-2) 2-ethoxy-6-iodo-3-propylbenzopyran-4-one (known from WO03/014103) of the formula

(23-3) 6-iodo-2-propoxy-3-propylbenzopyran-4-one (known from WO03/014103) of the formula

(23-4) 2-but-2-ynyloxy-6-iodo-3-propylbenzopyran-4-one (known from WO03/014103) of the formula

(23-5) 6-iodo-2-(1-methylbutoxy)-3-propylbenzopyran-4-one (known from WO03/014103) of the formula

(23-6) 2-but-3-enyloxy-6-iodobenzopyran-4-one (known from WO 03/014103)of the formula

(23-7) 3-butyl-6-iodo-2-isopropoxybenzopyran-4-one (known from WO03/014103) of the formula

Surprisingly, the fungicidal activity of the active compoundcombinations according to the invention is substantially higher than thesum of the activities of the individual active compounds. Thus, anunforeseeable true synergistic effect is present, and not just anaddition of activities.

The formula (I) provides a general definition of the compounds of group(1).

Preference is given to carboxamides of the formula (I) in which

-   R represents hydrogen or methyl,-   G represents hydrogen or methyl,-   R¹ represents hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl,    isopropyl, monofluoromethyl, difluoromethyl, trifluoromethyl,    monochloromethyl, dichloromethyl or trichloromethyl,-   A represents one of the radicals A1 or A2 below:

-   X represents CH or N,-   R² represents methyl, difluoromethyl or trifluoromethyl,-   R³ represents hydrogen or fluorine,-   R⁴ represents difluoromethyl or trifluoromethyl.

The formula (I) comprises in particular the following preferred mixingpartners of group (1):

-   (1-1)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-2)    1-methyl-3-(trifluoromethyl)-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-3)    1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-4)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-5)    3-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrazole-4-carboxamide-   (1-6)    3-(difluoromethyl)-1-methyl-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-7)    3-(difluoromethyl)-1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-8)    3-(difluoromethyl)-N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrazole-4-carboxamide-   (1-9)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide-   (1-10)    5-fluoro-1,3-dimethyl-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-11)    5-fluoro-1,3-dimethyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-12)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide-   (1-13)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide-   (1-14)    1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-3-(trifluoromethyl)-1H-pyrrole-4-carboxamide-   (1-15)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrrole-4-carboxamide-   (1-16)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrrole-4-carboxamide-   (1-17)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrrole-3-carboxamide-   (1-18)    4-(difluoromethyl)-1-methyl-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-19)    4-(difluoromethyl)-1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-20)    4-(difluoromethyl)-N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrrole-3-carboxamide-   (1-21)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-fluoro-1,4-dimethyl-1H-pyrrole-3-carboxamide-   (1-22)    5-fluoro-1,4-dimethyl-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-23)    5-fluoro-1,4-dimethyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-24)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,4-dimethyl-1H-pyrrole-3-carboxamide-   (1-25)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-26)    2-methyl-4-(trifluoromethyl)-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1,3-thiazole-5-carboxamide-   (1-27)    2-methyl-N-[2-(3-methylbutyl)-3-thienyl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-28)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-29)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-1,3-thiazole-5-carboxamide-   (1-30)    4-(difluoromethyl)-2-methyl-N-[2-(1,3,3-trimethylbutyl)-3-thienyl]-1,3-thiazole-5-carboxamide-   (1-31)    4-(difluoromethyl)-2-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1,3-azole-5-carboxamide-   (1-32)    4-(difluoromethyl)-N-[2-(3,3-dimethylbutyl)-3-thienyl]-2-methyl-1,3-thiazole-5-carboxamide

Emphasis is given to active compound combinations according to theinvention comprising in addition to the carboxamide (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(group 1) one or more, preferably one, mixing partner from groups (2) to(23).

Emphasis is given to active compound combinations according to theinvention comprising in addition to the carboxamide (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide(group 1) one or more, preferably one, mixing partner from groups (2) to(23).

Emphasis is given to active compound combinations according to theinvention comprising in addition to the carboxamide (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide(group 1) one or more, preferably one, mixing partner from groups (2) to(23).

Emphasis is given to active compound combinations according to theinvention comprising in addition to the carboxamide (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide(group 1) one or more, preferably one, mixing partner from groups (2) to(23).

The compound (6-6) carpropamid has three asymmetrically substitutedcarbon atoms. Accordingly, the compound (6-7) can be present as amixture of various isomers or else in the form of a single component.Particular preference is given to the compounds(1S,3R)-2,2-dichloro-N-[(1R)-1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamideof the formula

and(1R,3S)-2,2-dichloro-N-[(1R)-1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamideof the formula

Preferred mixing partners are the following active compounds of groups(2) to (23): (2-1) fluoxastrobin, (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(2-3) trifloxystrobin, (2-4)(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide,(2-5)(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}amino)methyl]phenyl}ethanamide,(2-7)5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,(2-8) dimoxystrobin, (2-9) picoxystrobin, (2-10) pyraclostrobin, (3-3)propiconazole, (3-4) difenoconazole, (3-6) cyproconazole, (3-7)hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3-10)tetraconazole, (3-13) flusilazole, (3-15) prothioconazole, (3-16)fenbuconazole, (3-17) tebuconazole, (3-21) bitertanol, (3-22)triadimenol, (3-23) triadimefon, (3-12) epoxiconazole, (3-19)metconazole, (3-21) fluquinconazole, (4-1) dichlofluanid, (4-2)tolylfluanid, (5-1) iprovalicarb, (5-2) benthiavalicarb, (6-2) boscalid,(6-4) ethaboxam, (6-5) fenhexamid, (6-6) carpropamid, (6-7)2-chloro-4-[(2-fluoro-2-methylpropanoyl)amino]-N,N-dimethylbenzamide,(6-8) picobenzamid, (6-9) zoxamide, (6-10)3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide, (7-1) mancozeb,(7-2) maneb, (7-4) propineb, (7-5) thiram, (7-6) zineb, (8-1) benalaxyl,(8-2) furalaxyl, (8-3) benalaxyl-M (9-1) cyprodinil, (9-2) pyrimethanil,(10-1)6-chloro-5-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-2,2-difluoro-5H-[1,3]dioxolo[4,5-f]benzimidazole,(10-3) carbendazim, (11-1) propamocarb, (11-2) propamocarbhydrochloride, (11-3) propamocarb-fosetyl, (12-2) folpet, (12-3)iprodione, (12-4) procymidone, (13-1) dodine, (13-2) guazatine, (13-3)iminoctadine triacetate, (14-1) cyazofamid, (14-2) prochloraz, (14-3)triazoxide, (15-4) fenpropimorph, (17-1) phosphonic acid, (19-1)acibenzolar-S-methyl, (19-3) famoxadone, (19-4) oxadixyl, (19-5)spiroxamine, (19-8) fenamidone, (19-15)2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yl-1-yloxy)acetamide,(19-16) quinoxyfen, (19-17) proquinazid, (20-1) pencycuron, (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine,(22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(23-1) 2-butoxy-6-iodo-3-propylbenzopyran-4-one, (23-2)2-ethoxy-6-iodo-3-propylbenzopyran-4-one, (23-3)6-iodo-2-propoxy-3-propylbenzopyran-4-one.

Particularly preferred mixing partners are the following activecompounds of groups (2) to (23): (2-1) fluoxastrobin, (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}-phenyl)-2-(methoxyimino)-N-methylethanamide,(2-3) trifloxystrobin, (3-15) prothioconazole, (3-17) tebuconazole,(3-21) bitertanol, (3-22) triadimenol, (3-24) fluquinconazole, (4-1)dichlofluanid, (4-2) tolylfluanid, (5-1) iprovalicarb, (6-5) fenhexamid,(6-6) carpropamid, (6-8) picobenzamid, (7-4) propineb, (8-3)benalaxyl-M, (9-2) pyrimethanil, (10-3) carbendazim, (11-3)propamocarb-fosetyl, (12-3) iprodione, (14-2) prochloraz, (14-3)triazoxide, (19-5) spiroxamine, (19-15)2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide,(22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine,(22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo[1,5-a]pyrimidine-7-amine.

Hereinbelow, preferred active compound combinations consisting of twogroups of active compounds and comprising in each ease at least onecarboxamide of the formula (I) (group 1) and at least one activecompound from the stated group (2) to (23) are described. Thesecombinations are the active compound combinations A to R.

Preference is given to active compound combinations A to R in which thecarboxamide of the formula (I) (group 1) is selected from the listbelow:

-   (1-1)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-3)    1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-5)    3-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrazole-4-carboxamide-   (1-7)    3-(difluoromethyl)-1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-9)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide-   (1-11)    5-fluoro-1,3-dimethyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrazole-4-carboxamide-   (1-13)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide-   (1-15)    N-[2-(3,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrrole-4-carboxamide-   (1-17)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrrole-3-carboxamide-   (1-19)    4-(difluoromethyl)-1-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-21)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-fluoro-1,4-dimethyl-1H-pyrrole-3-carboxamide-   (1-23)    5-fluoro-1,4-dimethyl-N-[2-(3-methylbutyl)-3-thienyl]-1H-pyrrole-3-carboxamide-   (1-25)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-27)    2-methyl-N-[2-(3-methylbutyl)-3-thienyl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-29)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-1,3-thiazole-5-carboxamide-   (1-31)    4-(difluoromethyl)-2-methyl-N-[2-(3-methylbutyl)-3-thienyl]-1,3-thiazole-5-carboxamide

Particular preference is given to active compound combinations A to R inwhich the carboxamide of the formula (I) (group 1) is selected from thelist below:

-   (1-1)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide-   (1-5)    3-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrazole-4-carboxamide-   (1-9)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide-   (1-13)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide-   (1-17)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-1H-pyrrole-3-carboxamide-   (1-21)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-fluoro-1,4-dimethyl-1H-pyrrole-3-carboxamide-   (1-25)    N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide-   (1-29)    4-(difluoromethyl)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations A in which thestrobilurin (group 2) is selected from the list below: (2-1)fluoxastrobin, (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(2-3) trifloxystrobin, (2-4)(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}-phenyl)ethanamide,(2-5)(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]-ethoxy}imino)methyl]phenyl}ethanamide,(2-6) orysastrobin, (2-7)5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,(2-8) dimoxystrobin, (2-9) picoxystrobin, (2-10) pyraclostrobin.

Particular preference is given to active compound combinations A inwhich the strobilurin (group 2) is selected from the following list:(2-1) fluoxastrobin, (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(2-3) trifloxystrobin, (2-8) dimoxystrobin, (2-9) picoxystrobin, (2-10)pyraclostrobin.

Emphasis is given to the active compound combinations A listed in table1 below:

TABLE 1 Active compound combinations A No. Carboxamide of the formula(I) Strobilurin (group 2) A-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-1) fluoxastrobin 3-(trifluoromethyl)-1H-pyrazole-4-carboxamide A-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphen-3-(trifluoromethyl)-1H-pyrazole-4-carboxamideoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide A-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-3) trifloxystrobin3-(trifluoromethyl)-1H-pyrazole-4-carboxamide A-4 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-8) dimoxystrobin3-(trifluoromethyl)-1H-pyrazole-4-carboxamide A-5 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-9) picoxystrobin3-(trifluoromethyl)-1H-pyrazole-4-carboxamide A-6 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (2-10) pyraclostrobin3-(trifluoromethyl)-1H-pyrazole-4-carboxamide A-7 (1-9)N-[2-(1,3-dimethylbutyl)-3 -thienyl]-5-fluoro- (2-1) fluoxastrobin1,3-dimethyl-1H-pyrazole-4-carboxamide A-8 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphen- 1,3-dimethyl-1H-pyrazole-4-carboxamideoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide A-9 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (2-3) trifloxystrobin1,3-dimethyl-1H-pyrazole-4-carboxamide A-10 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (2-8) dimoxystrobin 1,3-dimethyl-1H-pyrazole-4-carboxamide A-11 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (2-9) picoxystrobin1,3-dimethyl-1H-pyrazole-4-carboxamide A-12 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (2-10) pyraclostrobin1,3-dimethyl-1H-pyrazole-4-carboxamide A-13 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-1) fluoxastrobinthyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide A-14 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphen-thyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamideoxy)-5-fluoro-4-pyrimidinyl]oxyl}phenyl)-2-(methoxyimino)-N-methylethanamide A-15 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-3) trifloxystrobinthyl-4-(trifluoromethyl)-1H- pyrrole-3-carboxamide A-16 (1-13) N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-8) dimoxystrobinthyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide A-17 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-9) picoxystrobinthyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide A-18 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-me- (2-10) pyraclostrobinthyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide A-19 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-1) fluoxastrobinthyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide A-20 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-2)(2E)-2-(2-{[6-(3-chloro-2-methylphen-thyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamideoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide A-21 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-3) trifloxystrobinthyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide A-22 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-8) dimoxystrobinthyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide A-23 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-9) picoxystrobinthyl-4-(trifluorornethyl)-1,3-thiazole-5-carboxamide A-24 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-me- (2-10) pyraclostrobinthyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations B in which thetriazole (group 3) is selected from the following list: (3-1)azaconazole, (3-2) etaconazole, (3-3) propiconazole, (3-4)difenoconazole, (3-5) bromuconazole, (3-6) cyproconazole, (3-7)hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3-10)tetraconazole, (3-11) flutriafol, (3-12) epoxiconazole, (3-13)flusilazole, (3-14) simeconazole, (3-15) prothioconazole, (3-16)fenbuconazole, (3-17) tebuconazole, (3-18) ipconazole, (3-19)metconazole, (3-20) triticonazole, (3-21) bitertanol, (3-22)triadimenol, (3-23) triadimefon, (3-24) fluquinconazole, (3-25)quinconazole.

Particular preference is given to active compound combinations B inwhich the triazole (group 3) is selected from the following list: (3-3)propiconazole, (3-4) difenoconazole, (3-6) cyproconazole, (3-7)hexaconazole, (3-15) prothioconazole, (3-17) tebuconazole, (3-19)metconazole, (3-21) bitertanol, (3-22) triadimenol, (3-24)fluquinconazole.

Emphasis is given to the active compound combinations B listed in table2 below:

TABLE 2 Active compound combinations B No. Carboxamide of the formula(I) Triazole (group 3) B-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-3) propiconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-4) difenoconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-6) cyproconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-4 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-7) hexaconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-5 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-15) prothioconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-6 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-17) tebuconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-7 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-19) metconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-8 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-21) bitertanol(trifluoromethyl)-1H-pyrazole-4-carboxamide B-9 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-22) triadimenol(trifluoromethyl)-1H-pyrazole-4-carboxamide B-10 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (3-24) fluquinconazole(trifluoromethyl)-1H-pyrazole-4-carboxamide B-11 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-3) propiconazoledimethyl-1H-pyrazole-4-carboxamide B-12 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-4) difenoconazoledimethyl-1H-pyrazole-4-carboxamide B-13 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-6) cyproconazoledimethyl-1H-pyrazole-4-carboxamide B-14 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-7) hexaconazoledimethyl-1H-pyrazole-4-carboxamide B-15 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-15) prothioconazoledimethyl-1H-pyrazole-4-carboxamide B-16 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-17) tebuconazoledimethyl-1H-pyrazole-4-carboxamide B-17 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-19) metconazoledimethyl-1H-pyrazole-4-carboxamide B-18 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-21) bitertanoldimethyl-1H-pyrazole-4-carboxamide B-19 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-22) triadimenoldimethyl-1H-pyrazole-4-carboxamide B-20 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (3-24) fluquinconazoledimethyl-1H-pyrazole-4-carboxamide B-21 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-3) propiconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-22 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-4) difenoconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-23 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-6) cyproconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-24 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-7) hexaconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-25 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-15) prothioconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-26 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-17) tebuconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-27 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-19) metconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-28 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-21) bitertanol(trifluoromethyl)-1H-pyrrole-3-carboxamide B-29 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-22) triadimenol(trifluoromethyl)-1H-pyrrole-3-carboxamide B-30 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (3-24) fluquinconazole(trifluoromethyl)-1H-pyrrole-3-carboxamide B-31 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-3) propiconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-32 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-4) difenoconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-33 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-6) cyproconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-34 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-7) hexaconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-35 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-15) prothioconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-36 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-17) tebuconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-37 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-19) metconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide B-38 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-21) bitertanol(trifluoromethyl)-1,3-thiazole-5-carboxamide B-39 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-22) triadimenol(trifluoromethyl)-1,3-thiazole-5-carboxamide B-40 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (3-24) fluquinconazole(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations C in which thesulfenamide (group 4) is selected from the following list: (4-1)dichlofluanid, (4-2) tolylfluanid.

Emphasis is given to the active compound combinations C listed in table3 below:

TABLE 3 Active compound combinations C No. Carboxamide of the formula(I) Sulfenamide (group 4) C-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (4-1) dichlofluanid(trifluoromethyl)-1H-pyrazole-4-carboxamide C-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (4-2) tolylfluanid(trifluoromethyl)-1H-pyrazole-4-carboxamide C-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (4-1) dichlofluaniddimethyl-1H-pyrazole-4-carboxamide C-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (4-2) tolylfluaniddimethyl-1H-pyrazole-4-carboxamide C-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (4-1) dichlofluanid(trifluoromethyl)-1H-pyrrole-3-carboxamide C-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (4-2) tolylfluanid(trifluoromethyl)-1H-pyrrole-3-carboxamide C-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (4-1) dichlofluanid(trifluoromethyl)-1,3-thiazole-5-carboxamide C-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (4-2) tolylfluanid(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations D in which thevalinamide (group 5) is selected from the following list: (5-1)iprovalicarb, (5-3) benthiavalicarb.

Emphasis is given to the active compound combinations D listed in table4 below:

TABLE 4 Active compound combinations D No. Carboxamide of the formula(I) Valinamide (group 5) D-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (5-1) iprovalicarb(trifluoromethyl)-1H-pyrazole-4-carboxamide D-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (5-2) benthiavalicarb(trifluoromethyl)-1H-pyrazole-4-carboxamide D-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (5-1) iprovalicarbdimethyl-1H-pyrazole-4-carboxamide D-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (5-2) benthiavalicarbdimethyl-1H-pyrazole-4-carboxamide D-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (5-1) iprovalicarb(trifluoromethyl)-1H-pyrrole-3-carboxamide D-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (5-2) benthiavalicarb(trifluoromethyl)-1H-pyrrole-3-carboxamide D-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (5-1) iprovalicarb(trifluoromethyl)-1,3-thiazole-5-carboxamide D-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (5-2) benthiavalicarb(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations E in which thecarboxamide (group 6) is selected from the list below: (6-1)2-chloro-N-(1,1,3-trimethylindan-4-yl)nicotinamide, (6-2) boscalid,(6-3) furametpyr, (6-4) ethaboxam, (6-5) fenhexamid, (6-6) carpropamid,(6-7)2-chloro-4-(2-fluoro-2-methylpropionylamino)-N,N-dimethylbenzamide,(6-8) picobenzamid, (6-9) zoxamide, (6-10)3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide, (6-11)carboxin, (6-12) tiadinil, (6-13) silthiofam.

Particular preference is given to active compound combinations E inwhich the carboxamide (group 6) is selected from the list below: (6-2)boscalid, (6-4) ethaboxam, (6-5) fenhexamid, (6-6) carpropamid, (6-7)2-chloro-4-(2-fluoro-2-methylpropionylamino)-N,N-dimethylbenzamide,(6-8) picobenzamid, (6-9) zoxamide, (6-10)3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide.

Very particular preference is given to active compound combinations E inwhich the carboxamide (group 6) is selected from the following list:(6-2) boscalid, (6-5) fenhexamid, (6-6) carpropamid, (6-8) picobenzamid.

Emphasis is given to the active compound combinations E listed in table5 below:

TABLE 5 Active compound combinations E No. Carboxamide of the formula(I) Carboxamide (group 6) E-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (6-2) boscalid(trifluoromethyl)-1H-pyrazole-4-carboxamide E-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (6-5) fenhexamid(trifluoromethyl)-1H-pyrazole-4-carboxamide E-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (6-6) carpropamid(trifluoromethyl)-1H-pyrazole-4-carboxamide E-4 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (6-8) picobenzamid(trifluoromethyl)-1H-pyrazole-4-carboxamide E-5 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (6-2) boscaliddimethyl-1H-pyrazole-4-carboxamide E-6 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (6-5) fenhexamiddimethyl-1H-pyrazole-4-carboxamide E-7 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (6-6) carpropamiddimethyl-1H-pyrazole-4-carboxamide E-8 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (6-8) picobenzamiddimethyl-1H-pyrazole-4-carboxamide E-9 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (6-2) boscalid(trifluoromethyl)-1H-pyrrole-3-carboxamide E-10 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (6-5) fenhexamid(trifluoromethyl)-1H-pyrrole-3-carboxamide E-11 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (6-6) carpropamid(trifluoromethyl)-1H-pyrrole-3-carboxamide E-12 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (6-8) picobenzamid(trifluoromethyl)-1H-pyrrole-3-carboxamide E-13 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (6-2) boscalid(trifluoromethyl)-1,3-thiazole-5-carboxamide E-14 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (6-5) fenhexamid(trifluoromethyl)-1,3-thiazole-5-carboxamide E-15 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (6-6) carpropamid(trifluoromethyl)-1,3-thiazole-5-carboxamide E-16 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (6-8) picobenzamid(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations F in which thedithiocarbamate (group 7) is selected from the following list: (7-1)mancozeb, (7-2) maneb, (7-4) propineb, (7-5) thiram, (7-6) zineb.

Particular preference is given to active compound combinations F inwhich the dithiocarbamate (group 7) is selected from the following list:(7-1) mancozeb, (7-4) propineb.

Emphasis is given to the active compound combinations F listed in table6 below:

TABLE 6 Active compound combinations F No. Carboxamide of the formula(I) Dithiocarbamate (group 7) F-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (7-1) mancozeb(trifluoromethyl)-1H-pyrazole-4-carboxamide F-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (7-4) propineb(trifluoromethyl)-1H-pyrazole-4-carboxamide F-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (7-1) mancozebdimethyl-1H-pyrazole-4-carboxamide F-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (7-4) propinebdimethyl-1H-pyrazole-4-carboxamide F-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (7-1) mancozeb(trifluoromethyl)-1H-pyrrole-3-carboxamide F-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (7-4) propineb(trifluoromethyl)-1H-1-pyrrole-3-carboxamide F-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (7-1) mancozeb(trifluoromethyl)-1,3-thiazole-5-carboxamide F-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (7-4) propineb(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations G in which theacylalanine (group 8) is selected from the following list: (8-1)benalaxyl, (8-2) furalaxyl, (8-5) benalaxyl-M.

Particular preference is given to active compound combinations G inwhich the acylalanine of the formula (VI) (group 8) is selected from thefollowing list: (8-5) benalaxyl-M.

Emphasis is given to the active compound combinations G listed in table7 below:

TABLE 7 Active compound combinations G No. Carboxamide of the formula(I) Acylalanine (group 8) G-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (8-5)benalaxyl-M 1H-pyrazole-4-carboxamide G-2 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (8-5)benalaxyl-M 1H-pyrazole-4-carboxamide G-3 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)- (8-5)benalaxyl-M 1H-pyrrole-3-carboxamide G-4 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)- (8-5)benalaxyl-M 1,3-thiazole-5-carboxamide

Preference is given to active compound combinations H in which theanilinopyrimidine (group 9) is selected from the following list: (9-1)cyprodinil, (9-2) pyrimethanil.

Emphasis is given to the active compound combinations H listed in table8 below:

TABLE 8 Active compound combinations H No. Carboxamide of the formula(I) Anilinopyrimidine (group 9) H-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (9-1) cyprodinil(trifluoromethyl)-1H-pyrazole-4-carboxamide H-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (9-2) pyrimethanil(trifluoromethyl)-1H-pyrazole-4-carboxamide H-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (9-1) cyprodinildimethyl-1H-pyrazole-4-carboxamide H-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (9-2) pyrimethanildimethyl-1H-pyrazole-4-carboxamide H-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (9-1) cyprodinil(trifluoromethyl)-1H-pyrrole-3-carboxamide H-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-l-methyl-4- (9-2) pyrimethaniltrifluoromethyl)-1H-pyrrole-3-carboxamide H-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (9-1) cyprodinil(trifluoromethyl)-1,3-thiazole-5-carboxamide H-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (9-2) pyrimethanil(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations I in which thebenzimidazole (group 10) is selected from the following list: (10-1)6-chloro-5-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-2,2-difluoro-5H-[1,3]dioxolo-[4,5-f]benzimidazole,(10-2) benomyl, (10-3) carbendazim, (10-4) chlorfenazole, (10-5)fuberidazole, (10-6) thiabendazole.

Particular preference is given to active compound combinations I inwhich the benzimidazole of the formula (VIII) (group 10) is: (10-3)carbendazim.

Emphasis is given to the active compound combinations I listed in table9 below:

TABLE 9 Active compound combinations I No. Carboxamide of the formula(I) Benzimidazole (group 10) I-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (10-3)carbendazim 1H-pyrazole-4-carboxamide I-2 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl-1H- (10-3)carbendazim pyrazole-4-carboxamide I-3 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-methyl-4-(trifluoromethyl)- (10-3)carbendazim 1H-pyrrole-3-carboxamide I-4 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)- (10-3)carbendazim 1,3-thiazole-5-carboxamide

Preference is given to active compound combinations J in which thecarbamate (group 11) is selected from the list below: (11-1)propamocarb, (11-2) propamocarb hydrochloride, (11-3)propamocarb-fosetyl.

Emphasis is given to the active compound combinations J listed in table10 below:

TABLE 10 Active compound combinations J Nr. Carboxamide of the formula(I) Carbamate (group 11) J-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (11-1) propamocarb(trifluoromethyl)-1H-pyrazole-4-carboxamide J-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (11-2) propamocarbhydrochloride (trifluoromethyl)-1H-pyrazole-4-carboxamide J-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (11-3)propamocarb-fosetyl (trifluoromethyl)-1H-pyrazole-4-carboxamide J-4(1-9) N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (11-1) propamocarb1,3-dimethyl-1H-pyrazole-4-carboxamide J-5 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (11-2) propamocarbhydrochloride 1,3-dimethyl-1H-pyrazole-4-carboxamide J-6 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (11-3) propamocarb-fosetyl1,3-dimethyl-1H-pyrazole-4-carboxamide J-7 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (11-1) propamocarb4-(trifluoromethyl)-1H-pyrrole-3-carboxamide J-8 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (11-2) propamocarbhydrochloride 4-(trifluoromethyl)-1H-pyrrole-3-carboxamide J-9 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (11-3) propamocarb-fosetyl4-(trifluoromethyl)-1H-pyrrole-3-carboxamide J-10 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (11-1) propamocarb4-(trifluoromethyl)-1,3-thiazole-5-carboxamide J-11 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (11-2) propamocarbhydrochloride 4-(trifluoromethyl)-1,3-thiazole-5-carboxamide J-12 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (11-3) propamocarb-fosetyl4-(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations K in which thedicarboximide (group 12) is selected from the list below: (12-2) folpet,(12-3) iprodione.

Emphasis is given to the active compound combinations K listed in table11 below:

TABLE 11 Active compound combinations K No. Carboxamide of the formula(I) Dicarboximide (group 12) K-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (12-2)folpet 1H-pyrazole-4-carboxamide K-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (12-3)iprodione 1H-pyrazole-4-carboxamide K-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (12-2) folpet1H-pyrazole-4-carboxamide K-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (12-3)iprodione 1H-pyrazole-4-carboxamide K-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (12-2) folpet(trifluoromethyl)-1H-pyrrole-3-carboxamide K-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (12-3) iprodione(trifluoromethyl)-1H-pyrrole-3-carboxamide K-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (12-2) folpet(trifluoromethyl)-1,3-thiazole-5-carboxamide K-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (12-3) iprodione(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations L in which theguanidine (group 13) is selected from the list below: (13-1) dodine,(13-2) guazatine.

Emphasis is given to the active compound combinations L listed in table12 below.

TABLE 12 Active compound combinations L No. Carboxamide of the formula(I) Guanidine (group 13) L-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (13-1)dodine 1H-pyrazole-4-carboxamide L-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (13-2)guazatine 1H-pyrazole-4-carboxamide L-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (13-1) dodine1H-pyrazole-4-carboxamide L-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (13-2)guazatine 1H-pyrazole-4-carboxamide L-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (13-1) dodine(trifluoromethyl)-1H-pyrrole-3-carboxamide L-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (13-2) guazatine(trifluoromethyl)-1H-pyrrole-3-carboxamide L-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (13-1) dodine(trifluoromethyl)-1,3-thiazole-5-carboxamide L-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)- (13-2)guazatine 1,3-thiazole-5-carboxamide

Preference is given to active compound combinations M in which theimidazole (group 14) is selected from the list below: (14-2) prochloraz,(14-3) triazoxide.

Emphasis is given to the active compound combinations M listed in table13 below:

TABLE 13 Active compound combinations M No. Carboxamide of the formula(I) Imidazole (group 14) M-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (14-2)prochloraz 1H-pyrazole-4-carboxamide M-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (14-3)triazoxide 1H-pyrazole-4-carboxamide M-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (14-2)prochloraz 1H-pyrazole-4-carboxamide M-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (14-3)triazoxide 1H-pyrazole-4-carboxamide M-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (14-2) prochloraz(trifluoromethyl)-1H-pyrrole-3-carboxamide M-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (14-3) triazoxide(trifluoromethyl)-1H-pyrrole-3-carboxamide M-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (14-2) prochloraz(trifluoromethyl)-1,3-thiazole-5-carboxamide M-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (14-3) triazoxide(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations N in which themorpholine (group 15) is selected from the following list: (15-1)aldimorph, (15-2) tridemorph, (15-3) dodemorph, (15-4) fenpropimorph.

Particular preference is given to active compound combinations N inwhich the morpholine (group 15) is selected from the list below: (15-4)fenpropimorph.

Emphasis is given to the active compound combinations N listed in table14 below:

TABLE 14 Active compound combinations N No. Carboxamide of the formula(I) Morpholine (group 15) N-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)- (15-4)fenpropimorph 1H-pyrazole-4-carboxamide N-2 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3-dimethyl- (15-4)fenpropimorph 1H-pyrazole-4-carboxamide N-3 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4-(trifluoromethyl)- (15-4)fenpropimorph 1H-pyrrole-3-carboxamide N-4 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4-(trifluoromethyl)- (15-4)fenpropimorph 1,3-thiazole-5-carboxamide

Preference is given to active compound combinations O in which thefungicide (group 19) is selected from the list below: (19-1)acibenzolar-5-methyl, (19-3) famoxadone, (19-4) oxadixyl, (19-5)spiroxamine, (19-8) fenamidone, (19-14)N-({4-[(cyclopropylamino)carbonyl]phenyl}sulfonyl)-2-methoxybenzamide,(19-15)2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]-ethyl}-2-(prop-2-yn-1-yloxy)acetamide.

Particular preference is given to active compound combinations O inwhich the fungicide (group 19) is selected from the list below: (19-5)spiroxamine, (19-14) N-([4-[(cyclopropylamino)carbonyl]-phenylsulfonyl)-2-methoxybenzamide, (19-15)2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide.

Emphasis is given to the active compound combinations O listed in table15 below:

TABLE 15 Active compound Combinations O No. Carboxamide of the formula (I) Fungicide (group 19) O-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-5) spiroxamine3-(trifluoromethyl)-1H-pyrazole-4-carboxamide O-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-14)N-({4-[(cyclopropylamino)- 3-(trifluoromethyl)-1H-pyrazole-4-carboxamidecarbonyl]phenyl}sulfonyl)-2-methoxy- benzamide O-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-15)2-(4-chlorophenyl)-N-{2-[3-3-(trifluoromethyl)-1H-pyrazole-4-carboxamidemethoxy-4-(prop-2-yn-1-yloxy)phenyl]-ethyl}-2-(prop-2-yn-1-yloxy)acetamide O-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (19-5) spiroxaminefluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide O-5 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (19-14)N-({4-[(cyclopropylamino)- fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamidecarbonyl]phenyl}sulfonyl)-2-methoxy- benzamide O-6 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (19-15)2-(4-chlorophenyl)-N-{2-[3-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamidemethoxy-4-(prop-2-yn-1-yloxy)phenyl]-ethyl}-2-(prop-2-yn-1-yloxy)acetamide O-7 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-5) spiroxamine4-(trifluoromethyl)-1H-pyrrole-3-carboxamide O-8 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-14)N-({4-[(cyclopropylamino)- 4-(trifluoromethyl)-1H-pyrrole-3-carboxamidecarbonyl]phenyl}sulfonyl)-2-methoxy- benzamide O-9 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (19-15)2-(4-chlorophenyl)-N-{2-[3- 4-(trifluoromethyl)-1H-pyrrole-3-carboxamidemethoxy-4-(prop-2-yn-1-yloxy)phenyl]-ethyl}-2-(prop-2-yn-1-yloxy)acetamide O-10 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (19-5) spiroxamine4-(trifluoromethyl)-1,3-thiazole-5-carboxamide O-11 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (19-14)N-({4-[(cyclopropylamino)-4-(trifluoromethyl)-1,3-thiazole-5-carboxamidecarbonyl]phenyl}sulfonyl)-2-methoxy- benzamide O-12 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (19-15)2-(4-chlorophenyl)-N-{2-[3-4-(trifluoromethyl)-1,3-thiazole-5-carboxamidemethoxy-4-(prop-2-yn-1-yloxy)phenyl]-ethyl}-2-(prop-2-yn-1-yloxy)acetamide

Preference is given to the active compound combinations P in which the(thio)urea derivative (group 20) is selected from the list below: (20-1)pencycuron.

Emphasis is given to the active compound combinations P listed in table16 below:

TABLE 16 Active compound combinations P No. Carboxamide of the formula(I) (Thio)urea derivative (group 20) P-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (20-1) pencycuron(trifluoromethyl)-1H-pyrazole-4-carboxamide P-2 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro- (20-1) pencycuron1,3-dimethyl-1H-pyrazole-4-carboxamide P-3 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- (20-1) pencycuron4-(trifluoromethyl)-1H-pyrrole-3-carboxamide P-4 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl- (20-1) pencycuron4-(trifluoromethyl)-1,3-thiazole-5-carboxamide

Preference is given to active compound combinations Q in which thetriazolopyrimidine (group 22) is selected from the list below: (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(22-3)5-chloro-6-(2-chloro-6-fluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine,(22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine.

Particular preference is given to active compound combinations Q inwhich the triazolopyrimidine (group 22) is selected from the list below:(22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,(22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]-triazolo[1,5-a]pyrimidine-7-amine,(22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine,(22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo[1,5-a]pyrimidine-7-amine.

Emphasis is given to the active compound combinations Q listed in table17 below:

TABLE 17 Active compound combinations Q No. Carboxamide of the formula(I) Triazolopyrimidine (group 22) Q-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-methylethyl]-6-(2,4,6-trifluorophenyl)- carboxamide[1,2,4]triazolo[1,5-a]pyrimidine-7-amine Q-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-methyl-3-(trifluoromethyl)-1H-pyrazole-4-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-3 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methyl-3-(trifluoromethyl)-1H-pyrazole-4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]- carboxamide pyrimidine Q-4(1-1) N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-methyl-3-(trifluoromethyl)-1H-pyrazole-4-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-5 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1- fluoro-1,3-dimethyl-1H-pyrazole-4-methylethyl]-6-(2,4,6-trifluorophenyl)- carboxamide[1,2,4]triazolo[1,5-a]pyrimidine-7-amine Q-6 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]- fluoro-1,3-dimethyl-1H-pyrazole-4-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-7 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-fluoro-1,3-dimethyl-1H-pyrazole-4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]- carboxamide pyrimidine Q-8(1-9) N-[2-(1,3-dimethylbutyl)-3-thienyl]-5- (22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N- fluoro-1,3-dimethyl-1H-pyrazole-4-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-9 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-1)5-chloro-N-(1S)-2,2,2-trifluoro-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-methylethyl]-6-(2,4,6-trifluorophenyl)- carboxamide[1,2,4]triazolo[1,5-a]pyrimidine-7-amine Q-10 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]-methyl-4-(trifluoromethyl)-1H-pyrrole-3-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo- carboxamide(1,5-a]pyrimidine-7-amine Q-11 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-4)5-chloro-6-(2,4,6-trifluorphenyl)-7-(4-methyl-4-(trifluoromethyl)-1H-pyrrole-3-methylpiperidin-1-yl)[1,2,4][1,5-a]- carboxamide pyrimidine Q-12 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1- (22-5)5-chloro-6-(2,4,6-trifluorphenyl)-N-methyl-4-(trifluoromethyl)-1H-pyrrole-3-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-13 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2- (22-1)5-chloro-N-[(1S)-2,2,2-trifluoro-1-methyl-4-(trifluoromethyl)-1,3-thiazole-5-methylethyl]-6-(2,4,6-trifluorophenyl)- carboxamide[1,2,4]triazolo[1,5-a]pyrimidine-7-amine Q-14 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2- (22-2)5-chloro-N-[(1R)-1,2-dimethylpropyl]methyl-4-(trifluoromethyl)-1,3-thiazole-5-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine Q-15 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2- (22-4)5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methyl-4-(trifluoromethyl)-1,3-thiazole-5-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]- carboxamide pyrimidine Q-16(1-25) N-[2-(1,3-dimethylbutyl)-3-thienyl]-2- (22-5)5-chloro-6-(2,4,6-trifluorophenyl)-N-methyl-4-(trifluoromethyl)-1,3-thiazole-5-[(1S)-1,2,2-trimethylpropyl][1,2,4]triazolo- carboxamide[1,5-a]pyrimidine-7-amine

Preference is given to active compound combinations R in which theiodochromone (group 23) is selected from the list below: (23-1)2-butoxy-6-iodo-3-propylbenzopyran-4-one, (23-2)2-ethoxy-6-iodo-3-propylbenzopyran-4-one, (23-3)6-iodo-2-propoxy-3-propylbenzopyran-4-one, (23-4)2-but-2-ynyloxy-6-iodo-3-propylbenzopyran-4-one, (23-5)6-iodo-2-(1-methylbutoxy)-3-propylbenzopyran-4-one, (23-6)2-but-3-enyloxy-6-iodobenzopyran-4-one, (23-7)3-butyl-6-iodo-2-isopropoxybenzopyran-4-one.

Particular preference is given to active compound combinations T inwhich the iodochromone (group 23) is selected from the list below:(23-1) 2-butoxy-6-iodo-3-propylbenzopyran-4-one, (23-2)2-ethoxy-6-iodo-3-propylbenzopyran-4-one.

Emphasis is given to the active compound combinations R listed in table18 below:

TABLE 18 Active compound combinations R Iodochromone of the formula No.Carboxamide of the formula (I) (XV) R-1 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (23-1)2-butoxy-6-iodo-3-propyl- (trifluoromethyl)-1H-pyrazole-4-carboxamidebenzopyran-4-one R-2 (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- (23-2)2-ethoxy-6-iodo-3-propyl- (trifluoromethyl)-1H-pyrazole-4-carboxamidebenzopyran-4-one R-3 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (23-1)2-butoxy-6-iodo-3-propyl- dimethyl-1H-pyrazole-4-carboxamidebenzopyran-4-one R-4 (1-9)N-[2-(1,3-dimethylbutyl)-3-thienyl]-5-fluoro-1,3- (23-2)2-ethoxy-6-iodo-3-propyl- dimethyl-1H-pyrazole-4-carboxamidebenzopyran-4-one R-5 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4 (23-1)2-butoxy-6-iodo-3-propyl- (trifluoromethyl)-1H-pyrrole-3-carboxamidebenzopyran-4-one R-6 (1-13)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-4- (23-2)2-ethoxy-6-iodo-3-propyl- (trifluoromethyl)-1H-pyrrole-3-carboxamidebenzopyran-4-one R-7 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (23-1)2-butoxy-6-iodo-3-propyl- (trifluoromethyl)-1,3-thiazole-5-carboxamidebenzopyran-4-one R-8 (1-25)N-[2-(1,3-dimethylbutyl)-3-thienyl]-2-methyl-4- (23-2)2-ethoxy-6-iodo-3-propyl- (trifluoromethyl)-1,3-thiazole-5-carboxamidebenzopyran-4-one

In addition to an active compound of the formula (I), the activecompound combinations according to the invention comprise at least oneactive compound selected from the compounds of groups (2) to (23). Inaddition, they may also comprise further fungicidally active additives.

The synergistic effect is particularly pronounced when the activecompounds in the active compound combinations according to the inventionare present in certain weight ratios. However, the weight ratios of theactive compounds in the active compound combinations can be variedwithin a relatively wide range. In general, the combinations accordingto the invention comprise active compounds of the formula (I) and amixing partner of one of groups (2) to (23) in the mixing ratios givenin an exemplary manner in table 19 below.

The mixing ratios are based on weight ratios. The ratio is to beunderstood as meaning active compound of formula (I):mixing partner.

TABLE 19 Mixing ratios particularly preferred preferred Mixing partnermixing ratio mixing ratio Group (2): Strobilurins  50:1 to 1:50 10:1 to1:20 Group (3): Triazoles  50:1 to 1:50 20:1 to 1:20 Group (4):Sulfenamides  1:1 to 1:150  1:1 to 1:100 Group (5): Valinamides  50:1 to1:50 10:1 to 1:20 Group (6): Carboxamides  50:1 to 1:50 20:1 to 1:20Group (7): Dithiocarbamates  1:1 to 1:150  1:1 to 1:100 Group (8):Acylalanines  10:1 to 1:150  5:1 to 1:100 Group (9): Anilinopyrimidines 5:1 to 1:50  1:1 to 1:20 Group (10): Benzimidazoles  10:1 to 1:50  5:1to 1:20 Group (11): Carbamates  1:1 to 1:150  1:1 to 1:100 Group (12):(12-1)/(12-2)  1:1 to 1:150  1:5 to 1:100 Group (12):(12-3)/(12-4)/(12-5)  5:1 to 1:50  1:1 to 1:20 Group (13): Guanidines100:1 to 1:150 20:1 to 1:100 Group (14): Imidazoles  50:1 to 1:50 10:1to 1:20 Group (15): Morpholines  50:1 to 1:50 10:1 to 1:20 Group (16):Pyrroles  50:1 to 1:50 10:1 to 1:20 Group (17): Phosphonates  10:1 to1:150  1:1 to 1:100 Group (18): Phenylethanamides  50:1 to 1:50 10:1 to1:20 Group (19)  50:1 to 1:150 20:1 to 1:100 Group (20): (Thio)ureaderivatives  50:1 to 1:50 10:1 to 1:20 Group (21): Amides  50:1 to 1:5010:1 to 1:20 Group (22): Triazolopyrimidines  50:1 to 1:50 10:1 to 1:20Group (23): Iodochromones  50:1 to 1:50 10:1 to 1:20

In each case, the mixing ratio is to be chosen such that a synergisticmixture is obtained. The mixing ratios between the compound of theformula (I) and a compound of one of the groups (2) to (23) may alsovary between the individual compounds of a group.

The active con pound combinations according to the invention have verygood fungicidal properties and can be used for controllingphytopathogenic fungi and bacteria.

In crop protection, fungicides can be used for controllingPlasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes,Ascomycetes, Basidiomycetes and Deuteromycetes.

In crop protection, bactericides can be used for controllingPseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceaeand Streptomycetaceae.

Some pathogens causing fungal and bacterial diseases which come underthe generic names listed above may be mentioned as examples, but not byway of limitation:

Diseases caused by powdery mildew pathogens, such as, for example,Blumeria species, such as, for example, Blumeria graminis;Podosphaera species, such as, for example, Podosphaera leucotricha;Sphaerotheca species, such as, for example, Sphaerotheca fuliginea;Uncinula species, such as, for example, Uncinula necator;Diseases caused by rust disease pathogens, such as, for example,Gymnosporangium species, such as, for example, Gymnosporangium sabinaeHemileia species, such as, for example, Hemileia vastatrix;Phakopsora species, such as, for example, Phakopsora pachyrhizi andPhakopsora meibomiae;Puccinia species, such as, for example, Puccinia recondita;Uromyces species, such as, for example, Uromyces appendiculatus;Diseases caused by pathogens from the group of the Oomycetes, such as,for example,Bremia species, such as, for example, Bremia lactucae;Peronospora species, such as, for example, Peronospora pisi or P.brassicae;Phytophthora species, such as, for example Phytophthora infestans;Plasmopara species, such as, for example, Plasmopara viticola;Pseudoperonospora species, such as, for example, Pseudoperonosporahumuli orPseudoperonospora cubensis;Pythium species, such as, for example, Pythium ultimum;Leaf blotch diseases and leaf wilt diseases caused, for example, byAlternaria species, such as, for example, Alternaria solani;Cercospora species, such as, for example, Cercospora beticola;Cladiosporium species, such as, for example, Cladiosporium cucumerinum;Cochliobolus species, such as, for example, Cochliobolus sativus(conidia form: Drechslera, Syn: Helminthosporium);Colletotrichum species, such as, for example, Colletotrichumlindemuthanium;Cycloconium species, such as, for example, Cycloconium oleaginum;Diaporthe species, such as, for example, Diaporthe citri;Elsinoe species, such as, for example, Elsinoe fawcettii;Gloeosporium species, such as, for example, Gloeosporium laeticolor;Glomerella species, such as, for example, Glomerella cingulata;Guignardia species, such as, for example, Guignardia bidwelli;Leptosphaeria species, such as, for example, Leptosphaeria maculans;Magnaporthe species, such as, for example, Magnaporthe grisea;Mycosphaerella species, such as, for example, Mycosphaerellegrarninicola;Phaeosphaeria species, such as, for example, Phaeosphaeria nodorum;Pyrenophora species, such as, for example, Pyrenophora teres;Ramularia species, such as, for example, Ramularia collo-cygni;Rhynchosporium species, such as, for example, Rhynchosporium secalis;Septoria species, such as, for example, Septoria apii;Typhula species, such as, for example, Typhula incarnata;Venturia species, such as, for example, Venturia inaequalis;Root and stem diseases caused, for example, byCorticium species, such as, for example, Corticium graminearurn;Fusarium species, such as, for example, Fusarium oxysporum;Gaeumannomyces species, such as, for example, Gaeumannomyces graminis;Rhizoctonia species, such as, for example Rhizoctonia solani;Tapesia species, such as, for example, Tapesia acuformis;Thielaviopsis species, such as, for example, Thielaviopsis basicola;Ear and panicle diseases (including corn cobs) caused, for example, byAlternaria species, such as, for example, Alternaria spp.;Aspergillus species, such as, for example, Aspergillus flavus;Cladosporium species, such as, for example, Cladosporium spp.;Claviceps species, such as, for example, Claviceps purpurea;Fusarium species, such as, for example, Fusarium culmorum;Gibberella species, such as, for example, Gibberella zeae;Monographella species, such as, for example, Monographella nivalis;Diseases caused by smut fungi, such as, for example,Sphacelotheca species, such as, for example, Sphacelotheca reiliana;Tilletia species, such as, for example, Tilletia caries;Urocystis species, such as, for example, Urocystis occulta;Ustilago species, such as, for example, Ustilago nuda;Fruit rot caused, for example, byAspergillus species, such as, for example, Aspergillus flavus;Botrytis species, such as, for example, Botrytis cinerea;Penicillium species, such as, for example, Penicillium expansum;Sclerotinia species, such as, for example, Sclerotinia sclerotiorum;Verticilium species, such as, for example, Verticilium alboatrum;Seed- and soil-borne rot and wilt diseases, and also diseases ofseedlings, caused, for example, byFusarium species, such as, for example, Fusarium culmorum;Phytophthora species, such as, for example, Phytophthora cactorum;Pythium species, such as, for example, Pythium ultimum;Rhizoctonia species, such as, for example, Rhizoctonia solani;Sclerotium species, such as, for example, Sclerotium rolfsii;Cancerous diseases, galls and witches' broom caused, for example, byNectria species, such as, for example, Nectria galligena;Wilt diseases caused, for example, byMonilinia species, such as, for example, Monilinia taxa;Deformations of leaves, flowers and fruits caused, for example, byTaphrina species, such as, for example, Taphrina deformans;Degenerative diseases of woody plants caused, for example, byEsca species, such as, for example, Phaemoniella clamydospora;Diseases of flowers and seeds caused, for example, byBotrytis species, such as, for example, Botrytis cinerea;Diseases of plant tubers caused, for example, byRhizoctonia species, such as, for example, Rhizoctonia solani;Diseases caused by bacteriopathogens, such as, for example,Xanthomonas species, such as, for example, Xanthomonas campestris pv.oryzae;Pseudomonas species, such as, for example, Pseudomonas syringae pv.lachrymans;Erwinia species, such as, for example, Erwinia amylovora.Preference is given to controlling the following diseases of soya beans:fungal diseases on leaves, stems, pods and seeds caused, for example, byalternaria leaf spot (Alternaria spec. atrans tenuissima), anthracnose(Colletotrichum gloeosporoides dematium var. trancatum), brown spot(Septoria glycines), cercospora leaf spot and blight (Cercosporakikuchii), choanephora leaf blight (Choanephora infundibulifera trispora(Syn.)), dactuliophora leaf spot (Dactuliophora glycines), downy mildew(Peronospora manshurica), drechslera blight (Drechslera glycini),frogeye leaf spot (Cercospora sojina), leptosphaerulina leaf spot(Leptosphaerulina trifolii), phyllostica leaf spot (Phyllostictasojaecola), powdery mildew (Microsphaera diffusa), pyrenochaeta leafspot (Pyrenochaeta glycines), rhizoctonia aerial, foliage, and webblight (Rhizoctonia solani), rust (Phakopsora pachyrhizi), scab(Sphaceloma glycines), steraphylium leaf blight (Stemphylium botryosum),target spot (Corynespora cassiicola)

Fungal diseases on roots and the stem base caused, for example, by blackroot rot (Calonectria crotalariae), charcoal rot (Macrophominaphaseolina), fusarium blight or wilt, root rot, and pod and collar rot(Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusariumequiseti), mycoleptodiscus root rot (Mycoleptodiscus terrestris),neocosmospora (Neocosmopspora vasinfecta), pod and stem blight(Diaporthe phaseolorum), stem canker (Diaporthe phaseolorum var.caulivora), phytophthora rot (Phytophthora megasperna), brown stem rot(Phialophora gregata), pythium rot (Pythium aphanidernatum, Pythiumirregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum),rhizoctonia root rot, stem decay, and damping-off (Rhizoctonia solani),sclerotinia stem decay (Sclerotinia sclerotiorum), sclerotinia Southernblight (Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsisbasicola).

The fact that the active compound combinations are well tolerated byplants at the concentrations required for controlling plant diseasespermits a treatment of entire plants (above-ground parts of plants androots), of propagation stock and seed, and of the soil. The activecompound combinations according to the invention can be used for foliarapplication or else as seed dressings.

The fact that the active compounds which can be used are well toleratedby plants at the concentrations required for controlling plant diseasespermits a treatment of the seed. Accordingly, the active compoundsaccording to the invention can be used as seed dressings.

A large part of the damage to crop plants which is caused byphytopathogenic fungi occurs as early as when the seed is attackedduring storage and after the seed is introduced into the soil, as wellas during and immediately after germination of the plants. This phase isparticularly critical since the roots and shoots of the growing plantare particularly sensitive and even minor damage can lead to the deathof the whole plant. Protecting the seed and the germinating plant by theuse of suitable compositions is therefore of particularly greatinterest.

The control of phytopathogenic fungi which damage plants post-emergenceis carried out primarily by treating the soil and the above-ground partsof plants with crop protection agents. Owing to the concerns regarding apossible impact of crop protection agents on the environment and thehealth of man and animals, there are efforts to reduce the amount ofactive compounds applied.

The control of phytopathogenic fungi by treating the seed of plants hasbeen known for a long time and is subject-matter of continuousimprovements. However, the treatment of seed entails a series ofproblems which cannot always be solved in a satisfactory manner. Thus,it is desirable to develop methods for protecting the seed and thegerminating plant which dispense with the additional application of cropprotection agents after sowing or after the emergence of the plants orwhere additional application is at least considerably reduced. It isfurthermore desirable to optimize the amount of active compound employedin such a way as to provide maximum protection for the seed and thegerminating plant from attack by phytopathogenic fungi, but withoutdamaging the plant itself by the active compound employed. Inparticular, methods for the treatment of seed should also take intoconsideration the intrinsic fungicidal properties of transgenic plantsin order to achieve optimum protection of the seed and the germinatingplant with a minimum of crop protection agents being employed.

The present invention therefore in particular also relates to a methodfor the protection of seed and germinating plants from attack byphytopathogenic fungi, by treating the seed with a composition accordingto the invention.

The invention likewise relates to the use of the compositions accordingto the invention for the treatment of seed for protecting the seed andthe germinating plant from phytopathogenic fungi.

Furthermore, the invention relates to seed which has been treated with acomposition according to the invention so as to afford protection fromphytopathogenic fungi.

One of the advantages of the present invention is that, because of theparticular systemic properties of the compositions according to theinvention, treatment of the seed with these compositions not onlyprotects the seed itself, but also the resulting plants after emergence,from phytopathogenic fungi. In this manner, the immediate treatment ofthe crop at the time of sowing or shortly thereafter can be dispensedwith.

Furthermore, it must be considered as advantageous that the mixturesaccording to the invention can also be employed in particular intransgenic seed.

The compositions according to the invention are suitable for protectingseed of any plant variety which is employed in agriculture, in thegreenhouse, in forests or in horticulture. In particular, this takes theform of seed of cereals (such as wheat, barley, rye, millet and oats),corn, cotton, soya beans, rice, potatoes, sunflowers, beans, coffee,beet (for example sugar beet and fodder beet), peanuts, vegetables (suchas tomatoes, cucumbers, onions and lettuce), lawn and ornamental plants.The treatment of seed of cereals (such as wheat, barley, rye and oats),corn and rice is of particular importance.

In the context of the present invention, the composition according tothe invention is applied to the seed either alone or in a suitableformulation. Preferably, the seed is treated in a state which is stableenough to avoid damage during treatment. In general, the seed may betreated at any point in time between harvest and sowing. The seedusually used has been separated from the plant and freed from cobs,shells, stalks, coats, hairs or the flesh of the fruit. Thus, forexample, it is possible to use seed which has been harvested, cleanedand dried to a moisture content of below 15% by weight. Alternatively,it is also possible to use seed which, after drying, has, for example,been treated with water and then dried again.

When treating the seed, care must generally be taken that the amount ofthe composition according to the invention applied to the seed and/orthe amount of further additives is chosen in such a way that thegermination of the seed is not adversely affected, or that the resultingplant is not damaged. This must be borne in mind in particular in thecase of active compounds which may have phytotoxic effects at certainapplication rates.

The compositions according to the invention can be applied directly,that is to say without comprising further components and without havingbeen diluted. In general, it is preferable to apply the composition tothe seed in the form of a suitable formulation. Suitable formulationsand methods for the treatment of seed are known to the skilled workerand are described, for example, in the following documents: U.S. Pat.No. 4,272,417 A, U.S. Pat. No. 4,245,432 A, U.S. Pat. No. 4,808,430 A,U.S. Pat. No. 5,876,739 A, US 2003/0176428 A1, WO 2002/080675 A1, WO2002/028186 A2.

The active compound combinations according to the invention are alsosuitable for increasing the yield of crops. In addition, they showreduced toxicity and are well tolerated by plants.

According to the invention, it is possible to treat all plants and partsof plants. Plants are to be understood here as meaning all plants andplant populations, such as desired and undesired wild plants or cropplants (including naturally occurring crop plants). Crop plants can beplants which can be obtained by conventional breeding and optimizationmethods or by biotechnological and genetic engineering methods orcombinations of these methods, including the transgenic plants andincluding plant cultivars which can or cannot be protected by plantbreeders' certificates. Parts of plants are to be understood as meaningall above-ground and below-ground parts and organs of plants, such asshoot, leaf, flower and root, examples which may be mentioned beingleaves, needles, stems, trunks, flowers, fruit-bodies, fruits and seedsand also roots, tubers and rhizomes. Parts of plants also includeharvested material and vegetative and generative propagation material,for example seedlings, tubers, rhizomes, cuttings and seeds.

The treatment of the plants and parts of plants according to theinvention with the active compounds is carried out directly or by actionon their environment, habitat or storage area according to customarytreatment methods, for example by dipping, spraying, evaporating,atomizing, broadcasting, brushing-on and, in the case of propagationmaterial, in particular in the case of seeds, furthermore by one- ormultilayer coating.

As already mentioned above, it is possible to treat all plants and theirparts according to the invention. In a preferred embodiment, wild plantspecies and plant cultivars, or those obtained by conventionalbiological breeding methods, such as crossing or protoplast fusion, andparts thereof, are treated. In a further preferred embodiment,transgenic plants and plant cultivars obtained by genetic engineeringmethods, if appropriate in combination with conventional methods(Genetically Modified Organisms), and parts thereof, are treated. Theterm “parts” or “parts of plants” or “plant parts” has been explainedabove.

Particularly preferably, plants of the plant cultivars which are in eachcase commercially available or in use are treated according to theinvention.

Depending on the plant species or plant cultivars, their location andgrowth conditions (soils, climate, vegetation period, diet), thetreatment according to the invention may also result in superadditive(“synergistic”) effects. Thus, for example, reduced application ratesand/or a widening of the activity spectrum and/or an increase in theactivity of the substances and compositions which can be used accordingto the invention, better plant growth, increased tolerance to high orlow temperatures, increased tolerance to drought or to water or soilsalt content, increased flowering performance, easier harvesting,accelerated maturation, higher harvest yields, better quality and/or ahigher nutritional value of the harvested products, better storagestability and/or processability of the harvested products are possiblewhich exceed the effects which were actually to be expected.

The transgenic plants or plant cultivars (i.e. those obtained by geneticengineering) which are preferably to be treated according to theinvention include all plaits which, in the genetic modification,received genetic material which imparted particularly advantageoususeful properties (“traits”) to these plants. Examples of suchproperties are Letter plant growth, increased tolerance to high or lowtemperatures, increased tolerance to drought or to water or soil saltcontent, increased flowering performance, easier harvesting, acceleratedmaturation, higher harvest yields, better quality and/or a highernutritional value of the harvested products, better storage stabilityand/or processability of the harvested products. Further andparticularly emphasized examples of such properties are a better defenseof the plants against animal and microbial pests, such as againstinsects, mites, phytopathogenic fungi, bacteria and/or viruses, and alsoincreased tolerance of the plants to certain herbicidally activecompounds. Examples of transgenic plants which may be mentioned are theimportant crop plants, such as cereals (wheat, rice), corn, soya beans,potatoes, cotton, oilseed rape and also frait plants (with the fruitsapples, pears, citrus fruits and grapes), and particular emphasis isgiven to corn, soya beans, potatoes, cotton and oilseed rape. Traitsthat are emphasized are in particular increased defense of the plantsagainst insects, by toxins formed in the plants, in particular thoseformed in the plants by the genetic material from Bacillus thuringiensis(for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA,CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof)(hereinbelow referred to as “Bt plants”). Traits that are furthermoreparticularly emphasized are the increased tolerance of the plants tocertain herbicidally active compounds, for example imidazolinones,sulfonylureas, glyphosate or phosphinotricin (for example the “PAT”gene). The genes which impart the desired traits in question can also bepresent in combination with one another in the transgenic plants.Examples of “Bt plants” which may be mentioned are corn varieties,cotton varieties, soya bean varieties and potato varieties which aresold under the trade names YIELD GARD® (for example corn, cotton, soyabeans), KnockOut® (for example corn), Starlink® (eg corn), Bollgard®(cotton), Nucotn® (cotton) and NewLeaf® (potato). Examples ofherbicidetolerant plants which may be mentioned are corn varieties,cotton varieties and soya bean varieties which are sold under the tradenames Roundup Ready® (tolerance to glyphosate, for example corn, cotton,soya beans), Liberty Link® (tolerance to phosphinotricin, for exampleoilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance tosulfonylureas, for example corn). Herbicide-resistant plants (plantsbred in a conventional manner for herbicide tolerance) which may bementioned also include the varieties sold under the name Clearfield®(for example corn). Of course, these statements also apply to plantcultivars which have these genetic traits or genetic traits still to bedeveloped, and which will be developed and/or marketed in the future.

Depending on their particular physical and/or chemical properties, theactive compound combinations according to the invention can be convertedinto the customary formulations, such as solutions, emulsions,suspensions, powders, dusts, foams, pastes, soluble powders, granules,aerosols, suspoemulsion concentrates, natural and synthetic materialsimpregnated with active compound and microencapsulations in polymericsubstances and in coating compositions for seed, and ULV cold and warmfogging formulations.

These formulations are produced in a known manner, for example by mixingthe active compounds or active compound combinations with extenders,that is liquid solvents, liquefied gases under pressure, and/or solidcarriers, optionally with the e use of surfactants, that is emulsifiersand/or dispersants, and/or foam formers.

If the extender used is water, it is also possible to employ, forexample, organic solvents as auxiliary solvents. Essentially, suitableliquid solvents are: aromatics such as xylene, toluene oralkylnaphthalenes, chlorinated aromatics or chlorinated aliphatichydrocarbons such as chlorobenzenes, chloroethylenes or methylenechloride, aliphatic hydrocarbons such as cyclohexane or paraffins, forexample petroleum fractions, mineral and vegetable oils, alcohols suchas butanol or glycol and their ethers and esters, ketones such asacetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone,strongly polar solvents such as dimethylformamide and dimethylsulfoxide, or else water.

Liquefied gaseous extenders or carriers are to be understood as meaningliquids which are gaseous at standard temperature and under atmosphericpressure, for example aerosol propellants such as butane, propane,nitrogen and carbon dioxide.

Suitable solid carriers are: for example ammonium salts and groundnatural minerals such as kaolins, clays, talc, chalk, quartz,attapulgite, montmorillonite or diatomaceous earth, and ground syntheticminerals such as finely divided silica, alumina and silicates. Suitablesolid carriers for granules are: for example crushed and fractionatednatural rocks such as calcite, marble, pumice, sepiolite and dolomite,or else synthetic granules of inorganic and organic meals, and granulesof organic material such as sawdust, coconut shells, corn cobs andtobacco stalks. Suitable emulsifiers and/or foam formers are: forexample nonionic and anionic emulsifiers, such as polyoxyethylene fattyacid esters, polyoxyethylene fatty alcohol ethers, for example alkylarylpolyglycol ethers, alkylsulfonates, alkyl sulfates, arylsulfonates, orelse protein hydrolyzates. Suitable dispersants are: for examplelignosulfite waste liquors and methylcellulose.

Tackifiers such as carboxymethylcellulose, natural and syntheticpolymers in the form of powders, granules or latexes, such as gumarabic, polyvinyl alcohol and polyvinyl acetate, or else naturalphospholipids such as cephalins and lecithins and syntheticphospholipids can be used in the formulations. Other possible additivesare mineral and vegetable oils.

It is possible to use colorants such as inorganic pigments, for exampleiron oxide, titanium oxide and Prussian Blue, and organic dyestuffs suchas alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs,and trace nutrients such as salts of iron, manganese, boron, copper,cobalt, molybdenum and zinc.

The active compound content of the use forms prepared from thecommercial formulations may be varied within wide ranges. Theconcentration of active compound of the use forms for controlling animalpests, such as insects and acarids, may be from 0.0000001 to 95% byweight of active compound and is preferably from 0.0001 to 1% by weight.Application is in a customary manner adapted to the use forms.

The formulations for controlling unwanted phytopathogenic fungigenerally comprise between 0.1 and 95% by weight of active compounds,preferably between 0.5 and 90%.

The active compound combinations according to the invention can be usedas such, in the form of their formulations or as the use forms preparedtherefrom, such as ready-to-use solutions, emulsifiable concentrates,emulsions, suspensions, wettable powders, soluble powders, dusts andgranules. They are used in a customary manner, for example by watering(drenching), drip irrigation, spraying, atomizing, broadcasting,dusting, foaming, spreading-on, and as a powder for dry seed treatment,a solution for seed treatment, a water-soluble powder for seedtreatment, a water-soluble powder for slum/treatment, or by encrustingetc.

The active compound combinations according to the invention can, incommercial formulations and in the use forms prepared from theseformulations, be present as a mixture with other active compounds, suchas insecticides, attractants, sterilants, bactericides, acaricides,nematicides, fungicides, growth regulators or herbicides.

When using the active compound combinations according to the invention,the application rates can be varied within a relatively wide range,depending on the kind of application. In the treatment of parts ofplants, the application rates of active compound combination aregenerally between 0.1 and 10 000 g/ha, preferably between 10 and 1000g/ha. In the treatment of seed, the application rates of active compoundcombination are generally between 0.001 and 50 g per kilogram of seed,preferably between 0.01 and 10 g per kilogram of seed. In the treatmentof the soil, the application rates of active compound combination aregenerally between 0.1 and 10 000 g/ha, preferably between 1 and 5000g/ha.

The active compound combinations can be used as such, in the form ofconcentrates or in the form of generally customary formulations, such aspowders, granules, solutions, suspensions, emulsions or pastes.

The formulations mentioned can be prepared in a manner known per se, forexample by mixing the active compounds with at least one solvent ordiluent, emulsifier, dispersant and/or binder or fixative, waterrepellent, if desired desiccants and UV stabilizers, and, if desired,colorants and pigments and other processing auxiliaries.

The good fungicidal action of the active compound combinations accordingto the invention is demonstrated by the examples below. While theindividual active compounds show weaknesses in their fungicidal action,the combinations show an action which exceeds a simple sum of actions.

A synergistic effect in the fungicides is always present when thefungicidal action of the active compound combinations exceeds the totalof the action of the active compounds when applied individually.

The expected fungicidal action for a given combination of two activecompounds can be calculated as follows, according to S. R. Colby(“Calculating Synergistic and Antagonistic Responses of HerbicideCombinations”, Weeds 1967, 15, 20-22):

If

-   X is the efficacy when employing active compound A at an application    rate of m g/ha,-   Y is the efficacy when employing active compound B at an application    rate of n g/ha and-   E is the efficacy when employing active compounds A and B at    application rates of m and n g/ha,    then

$E = {X + Y - \frac{X \times Y}{100}}$

Here, the efficacy is determined in %. 0% means an efficacy whichcorresponds to that of the control, whereas an efficacy of 100% meansthat no infection is observed.

If the actual fungicidal action exceeds the calculated value, the actionof the combination is superadditive, i.e. a synergistic effect ispresent. In this case, the actually observed efficacy must exceed thevalue calculated using the above formula for the expected efficacy (E).

USE EXAMPLES Example A Puccinia Test (Wheat)/Protective

Solvent: 50 parts by weight of N,N-dimethylacetamideEmulsifier: 1 part by weight of alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amounts of solvent andemulsifier or a commercial active compound formulation, and theconcentrate is diluted with water to the desired concentration.

To test for protective activity, young plants are sprayed with thepreparation of active compound at the stated application rate. After thespray coating has dried on, the plants are sprayed with a conidiasuspension of Puccinia recondita. The plants remain in an incubationcabin at 20° C. and 100% relative atmospheric humidity for 48 hours.

The plants are then placed in a greenhouse at a temperature of about 20°C. and a relative atmospheric humidity of 80% to promote the developmentof rust postules.

Evaluation is carried out 10 days after the inoculation. 0% meansinefficacy which corresponds to that of the control, whereas an efficacyof 100% means that no infection is observed.

TABLE A Puccinia test (wheat) protective Active compound Efficacy in %Active compounds application rate in g/ha found* calc.** (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- 250 67(trifluoromethyl)-1H-pyrazole-4-carboxamide (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3- 125 33(trifluoromethyl)-1H-pyrazole-4-carboxamide (2-9) picoxystrobin 250 94(3-6) cyproconazole 125 94 (9-1) cyprodinil 125 0 (3-7) hexaconazole 12578 (3-3) propiconazole 125 56 (1-1) + (2-9) picoxystrobin 1:1 (A-5)250 + 250 100 98 (1-1) + (3-6) cyproconazole 1:1 (B-3) 125 + 125 100 96(1-1) + (9-1) cyprodinil 1:1 (H-1) 125 + 125 44 33 (1-1) + (3-7)hexaconazole 1:1 (B-4) 125 + 125 100 85 (1-1) + (3-3) propiconazole 1:1(B-1) 125 + 125 78 70 *found = activity found **calc. = activitycalculated using Colby's formula

Example B Erysiphe Test (Wheat)/Protective

Solvent: 50 parts by weight of N,N-dimethylacetamideEmulsifier: 1 part by weight of alkylarylpolyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amounts of solvent andemulsifier or a commercial active compound formulation, and theconcentrate is diluted with water to the desired concentration.

To test for protective activity, young plants are sprayed with thepreparation of active compound at the stated application rate.

After the spray coating has dried on, the plants are dusted with sporesof Erysiphe graminis f.sp. tritici.

The plants are placed in a greenhouse at a temperature of about 20° C.and a relative atmospheric humidity of about 80% to promote thedevelopment of mildew pustules.

Evaluation is carried out 7 days after the inoculation. 0% means anefficacy which corresponds to that of the control, whereas an efficacyof 100% means that no infection is observed.

TABLE B Erysiphe test (wheat) protective Active compound Efficacy in %Active compound application rate in g/ha found* calc.** (1-1)N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl- 62.5 03-(trifluoromethyl)-1H-pyrazol-4-carboxamide (2-9) picoxystrobin 62.5 71(3-6) cyproconazole 62.5 57 (9-1) cyprodinil 62.5 0 (3-7) hexaconazole62.5 29 (3-3) propiconazole 62.5 29 (1-1) + (2-9) picoxystrobin 1:1(A-5) 62.5 + 62.5 86 71 (1-1) + (3-6) cyproconazole 1:1 (B-3) 62.5 +62.5 93 57 (1-1) + (9-1) cyprodinil 1:1 (H-1) 62.5 + 62.5 29 0 (1-1) +(3-7) hexaconazole 1:1 (B-4) 62.5 + 62.5 57 29 (1-1) + (3-3)propiconazole 1:1 (B-1) 62.5 + 62.5 57 29 *found = activity found**calc. = activity calculated using Colby's formula

1-17. (canceled)
 18. An active compound combination comprising (1-1) penthiopyrad, one anilinopyrimidine selected from the group comprising: (9-1) cyprodinil and (9-2) pyrimethanil, and optionally an extender, a surfactant, or a combination thereof, wherein the ratio of (1-1) penthiopyrad to the anilinopyrimidine is from 5:1 to 1:50, and wherein said (1-1) penthiopyrad and anilinopyrimidine are present in synergistic amounts.
 19. The active compound combination according to claim 18, wherein the anilinopyrimidine is (9-1) cyprodinil.
 20. The active compound combination according to claim 19, wherein the ratio of (1-1) penthiopyrad to (9-1) cyprodinil is from 1:1 to 1:20.
 21. The active compound combination according to claim 20, wherein the ratio of (1-1) penthiopyrad to (9-1) cyprodinil is 1:1.
 22. The active compound combination according to claim 18, wherein the anilinopyrimidine is (9-2) pyrimethanil.
 23. The active compound combination according to claim 22, wherein the ratio of (1-1) penthiopyrad to (9-2) pyrimethanil is from 1:1 to 1:20.
 24. A seed treated with the active compound combination according to claim
 18. 25. A method for controlling unwanted phytopathogenic fungi, or treating seeds or transgenic plants comprising contacting said fungi, seeds, transgenic plants or their habitat with an active compound combination comprising (1-1) penthiopyrad, one anilinopyrimidine selected from the group comprising (9-1) cyprodinil and (9-2) pyrimethanil, and optionally an extender, a surfactant, or a combination thereof, wherein the ratio of (1-1) penthiopyrad to the anilinopyrimidine is from 5:1 to 1:50, and wherein said (1-1) penthiopyrad and anilinopyrimidine are present in synergistic amounts.
 26. The method according to claim 25, wherein said fungi are rust disease pathogens.
 27. The method according to claim 26, wherein said rust disease pathogens are Puccinia species.
 28. The method according to claim 27, wherein said Puccinia species are Puccinia recondita.
 29. The method according to claim 25, wherein said fungi are Erysiphe graminis Esp. tritici.
 30. The method according to claim 25, wherein said fungi are Alternaria species.
 31. The method according to claim 30, wherein said Alternaria species are Alternaria solani.
 32. The method according to claim 25, wherein said fungi are Sphaerotheca species.
 33. The method according to claim 32, wherein said Sphaerotheca species are Sphaerotheca fuliginea.
 34. The method according to claim 25, wherein said fungi are Venturia species.
 35. The method according to claim 34, wherein said Venturia species are Venturia inaequalis.
 36. The method according to claim 25, wherein said fungi are Septoria species. 